The TOP/FOP Flash assay was performed and revealed that MUC1 promoted the activity of β-catenin pathway in ESCC cells, but this promotion was ineffective again when SIGLEC9 in the co-cultured TAMs was blocked (Fig. 8g). Here, SIGLEC9 is linked to esophageal squamous cell carcinoma.